| Complete Home Health, Inc. | |
| 1753 Bertrand Drive, Lafayette, Louisiana 70506 | |
| (337) 233-0079 | |
| Name | Complete Home Health, Inc. |
|---|---|
| Location | 1753 Bertrand Drive, Lafayette, Louisiana |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 197456 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 70501, 70503, 70506, 70507, 70508, 70512, 70517, 70520, 70521, 70525, 70529, 70533, 70548, 70551, 70560, 70563, 70570, 70578, 70582, 70583, 70592, 70615, 70665, 71341 |
| NPI Number | 1114003985 |
| Organization Name | COMPLETE HOME HEALTH, INC. |
| Address | 1753 Bertrand Dr, Lafayette, LA 70506 |
| Phone Number | 337-233-0079 |
News Archive
A radiation therapy that uses multiple radiation beams to target tumors precisely has been shown to eliminate the primary tumor and ultimately may improve survival rates for lung-cancer patients unable to undergo surgery, according to UT Southwestern Medical Center physicians who led a national clinical trial of the treatment.
Eli Lilly and Company and Locemia Solutions today announced Lilly has acquired worldwide rights to Locemia's intranasal glucagon, a potential treatment for severe hypoglycemia in people with diabetes treated with insulin. Intranasal glucagon, which is currently in Phase III clinical trial testing, could be the first needle-free rescue treatment for severe hypoglycemia.
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences (PNAS).
HHS Secretary Tommy G. Thompson today urged people with Medicare to take advantage of real savings on their prescription medicines by signing up for Medicare-approved drug discount cards.
› Verified 8 days ago
| Quality Rating: |
News Archive
A radiation therapy that uses multiple radiation beams to target tumors precisely has been shown to eliminate the primary tumor and ultimately may improve survival rates for lung-cancer patients unable to undergo surgery, according to UT Southwestern Medical Center physicians who led a national clinical trial of the treatment.
Eli Lilly and Company and Locemia Solutions today announced Lilly has acquired worldwide rights to Locemia's intranasal glucagon, a potential treatment for severe hypoglycemia in people with diabetes treated with insulin. Intranasal glucagon, which is currently in Phase III clinical trial testing, could be the first needle-free rescue treatment for severe hypoglycemia.
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences (PNAS).
HHS Secretary Tommy G. Thompson today urged people with Medicare to take advantage of real savings on their prescription medicines by signing up for Medicare-approved drug discount cards.
› Verified 8 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 100 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 100 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 52.5 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 69 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
A radiation therapy that uses multiple radiation beams to target tumors precisely has been shown to eliminate the primary tumor and ultimately may improve survival rates for lung-cancer patients unable to undergo surgery, according to UT Southwestern Medical Center physicians who led a national clinical trial of the treatment.
Eli Lilly and Company and Locemia Solutions today announced Lilly has acquired worldwide rights to Locemia's intranasal glucagon, a potential treatment for severe hypoglycemia in people with diabetes treated with insulin. Intranasal glucagon, which is currently in Phase III clinical trial testing, could be the first needle-free rescue treatment for severe hypoglycemia.
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences (PNAS).
HHS Secretary Tommy G. Thompson today urged people with Medicare to take advantage of real savings on their prescription medicines by signing up for Medicare-approved drug discount cards.
› Verified 8 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 82.3 | 79.6 |
| How often patients got better at getting in and out of bed | 98.4 | 81.1 |
| How often patients got better at bathing | 95.6 | 82.3 |
| How often patients’ breathing improved | 85.9 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 81.4 | 75 |
| How often home health patients had to be admitted to the hospital | 13 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 16.9 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 98.9 | 94 |
News Archive
A radiation therapy that uses multiple radiation beams to target tumors precisely has been shown to eliminate the primary tumor and ultimately may improve survival rates for lung-cancer patients unable to undergo surgery, according to UT Southwestern Medical Center physicians who led a national clinical trial of the treatment.
Eli Lilly and Company and Locemia Solutions today announced Lilly has acquired worldwide rights to Locemia's intranasal glucagon, a potential treatment for severe hypoglycemia in people with diabetes treated with insulin. Intranasal glucagon, which is currently in Phase III clinical trial testing, could be the first needle-free rescue treatment for severe hypoglycemia.
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences (PNAS).
HHS Secretary Tommy G. Thompson today urged people with Medicare to take advantage of real savings on their prescription medicines by signing up for Medicare-approved drug discount cards.
› Verified 8 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
A radiation therapy that uses multiple radiation beams to target tumors precisely has been shown to eliminate the primary tumor and ultimately may improve survival rates for lung-cancer patients unable to undergo surgery, according to UT Southwestern Medical Center physicians who led a national clinical trial of the treatment.
Eli Lilly and Company and Locemia Solutions today announced Lilly has acquired worldwide rights to Locemia's intranasal glucagon, a potential treatment for severe hypoglycemia in people with diabetes treated with insulin. Intranasal glucagon, which is currently in Phase III clinical trial testing, could be the first needle-free rescue treatment for severe hypoglycemia.
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences (PNAS).
HHS Secretary Tommy G. Thompson today urged people with Medicare to take advantage of real savings on their prescription medicines by signing up for Medicare-approved drug discount cards.
› Verified 8 days ago
The patient survey data of Complete Home Health, Inc. is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 87 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 80 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 75 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 83 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 69 | 78 |
News Archive
A radiation therapy that uses multiple radiation beams to target tumors precisely has been shown to eliminate the primary tumor and ultimately may improve survival rates for lung-cancer patients unable to undergo surgery, according to UT Southwestern Medical Center physicians who led a national clinical trial of the treatment.
Eli Lilly and Company and Locemia Solutions today announced Lilly has acquired worldwide rights to Locemia's intranasal glucagon, a potential treatment for severe hypoglycemia in people with diabetes treated with insulin. Intranasal glucagon, which is currently in Phase III clinical trial testing, could be the first needle-free rescue treatment for severe hypoglycemia.
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences (PNAS).
HHS Secretary Tommy G. Thompson today urged people with Medicare to take advantage of real savings on their prescription medicines by signing up for Medicare-approved drug discount cards.
› Verified 8 days ago
Lourdes Home Health Location: 5000 Ambassador Caffery Pkwy Suite 102, Lafayette, Louisiana 70508 Ratings: Phone: (337) 406-2539 | |
Acadian Homecare, Llc Location: 458 Heymann Blvd Bldg A, Lafayette, Louisiana 70503 Ratings: Phone: (337) 235-8185 | |
Amedisys Home Health Location: 4021-b Ambassador Caffery Parkway, Suite 100, Lafayette, Louisiana 70503 Ratings: Phone: (337) 989-6913 | |
Nursing Specialties Location: 1025 Camellia Blvd, Lafayette, Louisiana 70508 Ratings: Phone: (337) 266-9996 | |
Home Health Care 2000 - Lafayette Location: 1304 Bertrand Drive, Suite A2 And A3, Lafayette, Louisiana 70506 Ratings: Phone: (337) 593-1198 | |
First Option Home Health Location: 4906 Ambassador Caffery Pkwy Bldg A, Ste 1, Lafayette, Louisiana 70508 Ratings: Phone: (337) 235-9741 |